Related Experiment Videos
Recessive oncogenes, antioncogenes and tumour suppression
1Department of Haematology and Oncology, Institute of Child Health, London, UK.
British Medical Bulletin
|January 1, 1991
Summary
Cancer develops from accumulated genetic mutations. Identifying tumor suppressor genes, like those in retinoblastoma, aids in understanding oncogenesis and detecting carriers.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Oncogenesis arises from accumulated genetic mutations in a single cell.
- Mutations can lead to new cellular functions or loss of normal growth control.
- Evidence includes somatic cell hybrid studies and allele loss in tumors.
Purpose of the Study:
- To identify critical genes involved in cancer predisposition syndromes.
- To understand the normal functions of identified genes.
- To explore the role of tumor suppressor genes in oncogenesis.
Main Methods:
- Somatic cell hybridization and studies of allele loss in human tumors.
- Cytogenetic abnormality observations and genetic linkage studies.
- Gene identification, cloning, and functional analysis.
Main Results:
- Critical genes for retinoblastoma, Wilms' tumor, and colorectal cancer have been identified and cloned.
- Normal functions of these genes include transcription control and cell-cell interactions.
- The interaction between the retinoblastoma gene product and viral oncogenes was delineated.
Conclusions:
- Identification of tumor suppressor genes enhances understanding of oncogenesis.
- These findings may facilitate presymptomatic detection of individuals with mutant gene carriers.
- Understanding gene inactivation is crucial for cancer research.